| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |